Simplex Trading’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-491
Closed -$7.22K 9754
2025
Q4
$7.22K Buy
491
+454
+1,227% +$7.26K ﹤0.01% 7205
2025
Q3
$0 Buy
+37
New +$767 ﹤0.01% 9667

Other funds holding MRNY

Simplex Trading's MRNY Position: Q1 2026 in Review

Simplex Trading sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026, closing a stake of 491 shares — an estimated $7.22K sold.

Simplex Trading first reported a position in MRNY in Q3 2025 and held it in 2 quarters. The position peaked at $7.22K in Q4 2025. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

  • Simplex Trading reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 491 YieldMax MRNA Option Income Strategy ETF shares in Q1 2026, an estimated $7.22K.
  • Simplex Trading first reported a position in YieldMax MRNA Option Income Strategy ETF in Q3 2025 and held it in 2 quarters.
  • Simplex Trading's YieldMax MRNA Option Income Strategy ETF position peaked at $7.22K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.